Casalmaiocco, Italy

Mario Leone

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Icrom S.r.l.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mario Leone. Retrieved from https://idiyas.com/inventor/mario-leone-du26of1n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mario Leone

Introduction

Mario Leone is an accomplished inventor based in Casalmaiocco, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the production of sterile active pharmaceutical ingredients (APIs). His innovative approach has paved the way for advancements in ophthalmic products.

Latest Patents

Mario Leone holds a patent for the "Production of sterile active pharmaceutical ingredients." This invention refers to a process for preparing sterile APIs that are essential for the formulation of sterile products intended for ophthalmic use. The process involves gamma-ray sterilization treatment of the APIs powder in a protective atmosphere, ensuring the highest standards of sterility.

Career Highlights

Throughout his career, Mario has worked with notable companies such as Icrom S.r.l. and Icrom S.p.a. His experience in these organizations has allowed him to refine his skills and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Some of his coworkers include Pierfrancesco Morosini, who has collaborated with Mario on various projects. Their teamwork has been instrumental in advancing their shared goals in the pharmaceutical industry.

Conclusion

Mario Leone's contributions to the field of pharmaceuticals through his innovative patent and collaborations highlight his dedication to improving healthcare solutions. His work continues to influence the production of sterile active pharmaceutical ingredients, ensuring safer and more effective ophthalmic products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…